Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.33p
   
  • Change Today:
    -0.042p
  • 52 Week High: 6.40
  • 52 Week Low: 3.33
  • Currency: UK Pounds
  • Shares Issued: 380.86m
  • Volume: 64,052
  • Market Cap: £12.70m

Regulatory News

US State Regulatory Approvals Update 23-Mar-2023 07:00 RNS
First Mevalone authorisation for domestic use 30-Jan-2023 07:00 RNS
Trading Update 10-Jan-2023 07:00 RNS
Distribution Agreement for Mevalone in France 15-Dec-2022 07:00 RNS
Organic Certification in Greece 30-Nov-2022 07:00 RNS
AIM Rule 17 Notification 24-Oct-2022 12:00 RNS
Holding(s) in Company 03-Oct-2022 16:39 RNS
Eden Half Yearly Report 30-Sep-2022 07:00 RNS
Appointment of Auditor 28-Sep-2022 08:46 RNS
Eden granted US EPA regulatory approval 26-Sep-2022 07:00 RNS
Appointment of Non-Executive Director 02-Sep-2022 07:00 RNS
Trading Update 22-Aug-2022 07:00 RNS
Exercise of Options 07-Jul-2022 07:00 RNS
Result of AGM 29-Jun-2022 12:18 RNS
AGM Statement 29-Jun-2022 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 3.33p
Change Today -0.042p
% Change -1.23 %
52 Week High 6.40
52 Week Low 3.33
Volume 64,052
Shares Issued 380.86m
Market Cap £12.70m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.71% above the market average16.71% above the market average16.71% above the market average16.71% above the market average16.71% above the market average
11.86% above the sector average11.86% above the sector average11.86% above the sector average11.86% above the sector average11.86% above the sector average
Price Trend
80.13% below the market average80.13% below the market average80.13% below the market average80.13% below the market average80.13% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Income Not Available
Growth
60.24% below the market average60.24% below the market average60.24% below the market average60.24% below the market average60.24% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Eden Research Dividends

No dividends found

Trades for 31-Mar-2023

Time Volume / Share Price
10:15 14,052 @ 3.45p
09:48 50,000 @ 3.50p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page